Join us Saturday, February 14th!

Experts in lymphomas, plasma cell disorders, myeloproliferative neoplasms, acute myeloid leukemia, myelodysplastic syndrome, and coagulation disorders will provide exciting updates from ASH 2025 with a focus on the latest treatment advances relevant to your clinical practice. The day will include presentations, case reviews, and interactive question and answer sessions.

The Denver ASH Review target audience is community-based medical hematologists/oncologists, advanced practice providers, nurses, pharmacists, and other healthcare professionals involved in the treatment of patients with benign and malignant hematologic disorders!